Actavis buying Warner Chilcott in $8.5B deal
Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.
Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.
Business
May 20, 2013
0
0
We are seeing deadly heat and fires circle the world. The Intergovernmental Panel on Climate Change warns we are fast running out of time to secure a liveable and sustainable future. Without emergency action to stop mining ...
Environment
Sep 4, 2023
0
10